Book contents
- CASE STUDIES Stahl’s Essential Psychopharmacology
- Reviews
- CASE STUDIES: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- List of icons
- Abbreviations
- Case 1: The salutatorian who couldn’t speak: selective serotonin reuptake inhibitor (SSRI)-refractory anxiety in an adolescent
- Case 2: From anxious to activated: selective serotonin reuptake inhibitor (SSRI)-related activation
- Case 3: The girl who couldn’t sleep: posttraumatic stress disorder (PTSD) in a young girl
- Case 4: Depressed and still depressed: major depressive disorder (MDD) in an adolescent
- Case 5: A 13-year-old adolescent who feels “amazing”: selective serotonin reuptake inhibitor (SSRI)-induced mania in an adolescent
- Case 6: Counting on a cure: obsessive compulsive disorder (OCD) in an adolescent
- Case 7: Struggles in the second grade: attention-deficit hyperactivity disorder (ADHD) in a child
- Case 8: From prodrome to psychosis: early-onset schizophrenia
- Case 9: Too much, too little, or just right? Lithium dosing in an adolescent
- Case 10: Tic, tic, tic: motor and vocal tics in a boy
- Case 11: How slow can you go? Selective serotonin reuptake inhibitor (SSRI) withdrawal and discontinuation in an adolescent
- Case 12: The adolescent who doesn’t eat: anorexia nervosa in an adolescent
- Case 13: High or higher antidepressant concentrations? Cannabis-related drug interactions in an adolescent
- Case 14: The boy whose bed was always wet: nocturnal enuresis in a child
- Case 15: Counting sheep and counting treatment trials: insomnia disorder in an adolescent
- Case 16: Second-generation antipsychotics/mixed dopamine–serotonin receptor agonists (SGAs), side effects, and the autism spectrum: SGA-related side effects in a boy with autism spectrum disorder (ASD)
- Case 17: The “standard treatment” is earning a “D”: treatment-resistant schizophrenia
- Case 18: Symptoms, side effects, or both? Selective serotonin reuptake inhibitor (SSRI) tolerability and physical symptoms in an anxious adolescent
- Book part
- Case Studies Index
- Drugs Index
- References
Case 9: Too much, too little, or just right? Lithium dosing in an adolescent
Published online by Cambridge University Press: 09 February 2024
Book contents
- CASE STUDIES Stahl’s Essential Psychopharmacology
- Reviews
- CASE STUDIES: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- List of icons
- Abbreviations
- Case 1: The salutatorian who couldn’t speak: selective serotonin reuptake inhibitor (SSRI)-refractory anxiety in an adolescent
- Case 2: From anxious to activated: selective serotonin reuptake inhibitor (SSRI)-related activation
- Case 3: The girl who couldn’t sleep: posttraumatic stress disorder (PTSD) in a young girl
- Case 4: Depressed and still depressed: major depressive disorder (MDD) in an adolescent
- Case 5: A 13-year-old adolescent who feels “amazing”: selective serotonin reuptake inhibitor (SSRI)-induced mania in an adolescent
- Case 6: Counting on a cure: obsessive compulsive disorder (OCD) in an adolescent
- Case 7: Struggles in the second grade: attention-deficit hyperactivity disorder (ADHD) in a child
- Case 8: From prodrome to psychosis: early-onset schizophrenia
- Case 9: Too much, too little, or just right? Lithium dosing in an adolescent
- Case 10: Tic, tic, tic: motor and vocal tics in a boy
- Case 11: How slow can you go? Selective serotonin reuptake inhibitor (SSRI) withdrawal and discontinuation in an adolescent
- Case 12: The adolescent who doesn’t eat: anorexia nervosa in an adolescent
- Case 13: High or higher antidepressant concentrations? Cannabis-related drug interactions in an adolescent
- Case 14: The boy whose bed was always wet: nocturnal enuresis in a child
- Case 15: Counting sheep and counting treatment trials: insomnia disorder in an adolescent
- Case 16: Second-generation antipsychotics/mixed dopamine–serotonin receptor agonists (SGAs), side effects, and the autism spectrum: SGA-related side effects in a boy with autism spectrum disorder (ASD)
- Case 17: The “standard treatment” is earning a “D”: treatment-resistant schizophrenia
- Case 18: Symptoms, side effects, or both? Selective serotonin reuptake inhibitor (SSRI) tolerability and physical symptoms in an anxious adolescent
- Book part
- Case Studies Index
- Drugs Index
- References
Summary
Compared to adults, young adolescents treated with lithium may require higher mg/kg doses because of:
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential PsychopharmacologyChildren and Adolescents, pp. 137 - 154Publisher: Cambridge University PressPrint publication year: 2023
References
Birmaher, B., Axelson, D., Goldstein, B., et al. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the course and outcome of bipolar youth (COBY) study. Am J Psychiatry 2009; 166(7): 795–804. https://doi.org/10.1176/appi.ajp.2009.08101569Google Scholar
Castro, V. M., Roberson, A. M., McCoy, T. H., et al. Stratifying risk for renal insufficiency among lithium-treated patients: an electronic health record study. Neuropsychopharmacology 2016; 41(4): 1138–43. https://doi.org/10.1038/npp.2015.254Google Scholar
Clos, S., Rauchhaus, P., Severn, A., Cochrane, L., Donnan, P. T. Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: a population-based cohort study. Lancet Psychiatry 2015; 2(12): 1075–83. https://doi.org/10.1016/S2215-0366(15)00316-8Google Scholar
Correll, C. U., Sheridan, E. M., DelBello, M. P. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disord 2010; 12(2): 166–41. https://doi.org/10.1111/j.1399-5618.2010.00798.xGoogle Scholar
DelBello, M. P., Hanseman, D., Adler, C. M., Fleck, D. E., Strakowski, S. M. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry 2007; 164(4): 582–90. https://doi.org/10.1176/ajp.2007.164.4.582Google Scholar
Findling, R. L., Frazier, J. A., Kafantaris, V., et al. The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation. Child Adolesc Psychiatry Mental Health 2008; 2: 21. https://doi.org/10.1186/1753-2000-2-21Google Scholar
Findling, R. L., Kafantaris, V., Pavuluri, M., et al. Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol 2011; 21(3): 195–205. https://doi.org/10.1089/cap.2010.0084Google Scholar
Findling, R. L., Landersdorfer, C. B., Kafantaris, , V., et al. First-dose pharmacokinetics of lithium carbonate in children and adolescents. J Clin Psychopharmacol 2010; 30(4): 404–10. https://doi.org/10.1097/JCP.0b013e3181e66a62Google Scholar
Findling, R. L., McNamara, N. K., Pavuluri, M., et al. Lithium for the maintenance treatment of bipolar I disorder: a double-blind, placebo-controlled discontinuation study. J Am Acad Child Adolesc Psychiatry 2019; 58(2): 287–96. https://doi.org/10.1016/j.jaac.2018.07.901Google Scholar
Findling, R. L., Robb, A., McNamara, N. K. Lithium in the acute treatment of bipolar I disorder: a double-blind, placebo-controlled study. Pediatrics 2015; 136(5): 885–94. https://doi.org/10.1542/peds.2015-0743Google Scholar
Heald, A. H., Holland, D., Stedman, M., et al. Can we check serum lithium levels less often without compromising patient safety? BJPsych Open 2021; 8: e18. https://doi.org10.1192/bjo.2021.1027Google Scholar
Hunt, J. I., Case, B. G., Birmaher, B., et al. Irritability and elation in a large bipolar youth sample: relative symptom severity and clinical outcomes over 4 years. J Clin Psychiatry 2013; 74(1): e110–17. https://doi.org/10.4088/JCP.12m07874Google Scholar
Kirkham, E., Skinner, J., Anderson, T., et al. One lithium level >1.0 mmol/L causes an acute decline in eGFR: findings from a retrospective analysis of a monitoring database. BMJ Open 2014; 4: e006020. https://doi.org/10.1136/bmjopen-2014-006020Google Scholar
Landersdorfer, C. B., Findling, R. L., Frazier, J. A., Kafantaris, V., Kirkpatrick, C. M. J. Lithium in paediatric patients with bipolar disorder: implications for selection of dosage regimens via population pharmacokinetics/pharmacodynamics. Clinical Pharmacokinetics 2017; 56(1): 77–90. https://doi.org/10.1007/s40262-016-0430-3Google Scholar
Meyer, J. M., Stahl, S. M. The Lithium Handbook. Cambridge, UK: Cambridge University Press, 2023.Google Scholar
Solmi, M., Radua, J., Olivola, M., et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry 2022; 27(1): 281–95. https://doi.org/10.1038/s41380-021-01161-7Google Scholar
van Meter, A. R., Burke, C., Kowatch, R. A., Findling, R. L., Youngstrom, E. A. Ten-year updated meta-analysis of the clinical characteristics of pediatric mania and hypomania. Bipolar Disord 2016; 18(1): 19–32. https://doi.org/10.1111/bdi.12358Google Scholar
Yen, S., Stout, R., Hower, H., et al. The influence of comorbid disorders on the episodicity of bipolar disorder in youth. Acta Psychiatr Scand 2016; 133(4): 324–34. https://doi.org/10.1111/acps.12514Google Scholar